$0.74
1.98% today
Nasdaq, Feb 28, 09:18 pm CET
ISIN
US6901451079
Symbol
OM

Outset Medical Inc Target price 2025 - Analyst rating & recommendation

Outset Medical Inc Classifications & Recommendation:

Buy
60%
Hold
40%

Outset Medical Inc Price Target

Target Price $3.75
Price $0.73
Potential
Number of Estimates 4
4 Analysts have issued a price target Outset Medical Inc 2026 . The average Outset Medical Inc target price is $3.75. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 5 analysts: 3 Analysts recommend Outset Medical Inc to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Outset Medical Inc stock has an average upside potential 2026 of . Most analysts recommend the Outset Medical Inc stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 113.69 120.26
12.80% 5.78%
Net Margin -114.55% -48.87%
18.93% 57.34%

5 Analysts have issued a sales forecast Outset Medical Inc 2025 . The average Outset Medical Inc sales estimate is

$120m
Unlock
. This is
5.78% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$121m 6.25%
Unlock
, the lowest is
$120m 5.55%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $114m 12.80%
2025
$120m 5.78%
Unlock
2026
$136m 12.78%
Unlock
2027
$155m 13.92%
Unlock
2028
$187m 21.17%
Unlock
2029
$210m 12.02%
Unlock

2 Outset Medical Inc Analysts have issued a net profit forecast 2025. The average Outset Medical Inc net profit estimate is

$-58.8m
Unlock
. This is
55.42% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-15.9m 87.95%
Unlock
, the lowest is
$-102m 22.90%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-130m 29.31%
2025
$-58.8m 54.88%
Unlock
2026
$-55.9m 4.95%
Unlock

Net Margin

2024 -114.55% 18.93%
2025
-48.87% 57.34%
Unlock
2026
-41.18% 15.74%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -2.46 -1.11
29.31% 54.88%
P/E negative
EV/Sales 0.68

2 Analysts have issued a Outset Medical Inc forecast for earnings per share. The average Outset Medical Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-1.11
Unlock
. This is
55.42% higher
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-0.30 87.95%
Unlock
, the lowest is
$-1.92 22.89%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-2.46 29.31%
2025
$-1.11 54.88%
Unlock
2026
$-1.06 4.50%
Unlock

P/E ratio

Current -0.29 72.64%
2025
-0.66 127.59%
Unlock
2026
-0.69 4.55%
Unlock

Based on analysts' sales estimates for 2025, the Outset Medical Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.72 22.58%
2025
0.68 5.03%
Unlock
2026
0.61 11.33%
Unlock
2027
0.53 12.22%
Unlock
2028
0.44 17.46%
Unlock
2029
0.39 10.74%
Unlock

P/S ratio

Current 0.34 76.16%
2025
0.32 5.47%
Unlock
2026
0.29 11.33%
Unlock
2027
0.25 12.22%
Unlock
2028
0.21 17.44%
Unlock
2029
0.19 10.73%
Unlock

Current Outset Medical Inc Upgrades & Downgrades Beta

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
RBC Capital Locked ➜ Locked Locked Jan 07 2025
Analyst Rating Date
Locked
RBC Capital: Locked ➜ Locked
Jan 07 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today